Insider Trading July 1, 2026 07:21 PM

HRT Financial Accumulates Shuttle Pharmaceuticals Shares as Stock Trades Near Lows

Investment firm increases position with $110,694 in purchases, while Shuttle finalizes merger with United Dogecoin and prepares for reverse stock split

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
SHPH

HRT Financial LP has expanded its stake in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) through recent acquisitions, buying $110,694 worth of common stock. The investment firm's purchases occurred as the stock traded near its 52-week low of $2.90, following a 92% decline over the past year. Concurrently, Shuttle Pharmaceuticals completed its merger with United Dogecoin Inc., integrating cryptocurrency mining operations into its business model.

HRT Financial Accumulates Shuttle Pharmaceuticals Shares as Stock Trades Near Lows
SHPH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • HRT Financial LP increased its stake in Shuttle Pharmaceuticals by purchasing $110,694 worth of common stock on June 29 and 30, 2026, at prices between $3.23 and $3.44 per share.
  • Shuttle Pharmaceuticals completed its merger with United Dogecoin Inc., issuing 8,000 shares of Series B-1 Convertible Preferred Stock convertible into approximately 32,264,000 common shares pending approval.
  • Shuttle approved a 10-for-1 reverse stock split and is expanding into cryptocurrency mining through United Dogecoin's acquisition of ElphaPex DG1+ units and a renewable energy site.

HRT Financial LP, which holds a ten percent stake in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH), has increased its ownership through a series of recent stock acquisitions. The investment firm purchased a total of $110,694 in common stock, with transactions executed on June 29 and June 30, 2026. These purchases were made at prices ranging from $3.23 to $3.44 per share, reflecting activity near the stock's 52-week low of $2.90 and a period where the shares have declined 92% over the past year. On June 29, the firm acquired 25,836 shares at $3.44 each, followed by an additional 6,755 shares at $3.23 per share on June 30. Following these transactions, HRT Financial LP directly holds 78,597 shares of Shuttle Pharmaceuticals common stock. A report detailing these transactions was filed on July 1, 2026. According to InvestingPro analysis, the stock appears undervalued at current levels, with a Fair Value estimate exceeding the recent trading price.

In a significant strategic development, Shuttle Pharmaceuticals announced the completion of its merger with United Dogecoin Inc., making the latter a wholly owned subsidiary. As part of this merger, Shuttle issued 8,000 shares of Series B-1 Convertible Preferred Stock to United Dogecoin equity holders, which are convertible into approximately 32,264,000 shares of common stock pending stockholder approval. Additionally, Shuttle Pharmaceuticals approved a 10-for-1 reverse stock split of its common stock, effective shortly. This move will adjust the trading of its common stock on the Nasdaq Capital Market under a new CUSIP number. United Dogecoin, now under Shuttle's umbrella, has purchased ElphaPex DG1+ mining units and secured a renewable energy-accessible mining site. The company plans to have its initial mining fleet operational within about 60 days, dependent on delivery and installation schedules. Shuttle has also confirmed a purchase order option for up to 3,000 ElphaPex Scrypt mining rigs to support Dogecoin and Litecoin mining operations. These developments indicate a strategic shift and expansion in Shuttle's business operations.

Risks

  • The conversion of preferred stock into approximately 32,264,000 common shares pending stockholder approval could impact the capital structure and dilute existing shareholders.
  • The operational timeline for United Dogecoin's initial mining fleet, dependent on delivery and installation schedules, introduces execution risk to the strategic expansion.
  • The 10-for-1 reverse stock split and new CUSIP number may affect market liquidity and trading dynamics on the Nasdaq Capital Market.

More from Insider Trading

Delek US Holdings Director Executes $257,500 Share Sale Under Pre-Arranged Plan Jul 1, 2026 Playboy Executives Reduce Holdings Amid Stock Pressure Jul 1, 2026 CrowdStrike CEO Executes $1.8 Million Share Sale Under Pre-Arranged Plan Jul 1, 2026 TeraWulf CEO Paul Prager Executes $3.65 Million Stock Sale Amid Infrastructure Expansion Jul 1, 2026 CrowdStrike Executive Liquidation and Strategic AI Security Expansion Jul 1, 2026